அமெரிக்கா பத்திரங்கள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அமெரிக்கா பத்திரங்கள் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அமெரிக்கா பத்திரங்கள் இன்க் Today - Breaking & Trending Today

Avery Dennison Corporation (AVY) Q2 2021 Earnings Call Transcript


Operator
Ladies and gentlemen, thank you for standing by. [Operator Instructions] Welcome to Avery Dennison s earnings conference call for the second quarter ended on July 3, 2021. [Operator Instructions] will be available for replay from noon Pacific Time today through midnight Pacific Time, July 31. To access the replay, please dial (800) 633-8284 or +1 (402) 977-9140 for international callers. The conference ID number is 21969420.
I d now like to turn the call over to John Eble, Avery Dennison s Head of Investor Relations. Please go ahead.
John Eble
Executive of Investor Relations
Thank you, Maladin. Please note that throughout today s discussion, we ll be making references to non-GAAP financial measures. The non-GAAP measures that we use are defined, qualified and reconciled with GAAP on schedules A-4 to A-10 of the financial statements accompanying today s earnings release. We remind you that we ll make certain predictive statements that reflect our cur ....

United States , Neel Kumar Morgan Stanley , Josh Spector , Avery Dennison , Paretosh Misra Berenberg , Paretosh Misra , Mitch Butier , Ghansham Panjabi Baird , John Eble , Greg Lovins , Jeffrey Zekauskas , Christopher Kapsch , Jeffrey Zekauskas Jpmorgan , Anthony Pettinari , George Staphos , Maneel Kumar , John Mcnulty , Deon Stander , Ghansham Panjabi , Reflective Solutions , Loop Capital Markets , George Staphos Bank , America Securities Inc , Research Analyst , Information Solutions , Avery Dennison Corporation ,

Protalix BioTherapeutics Seeks Multiple Collaborative Partnerships To Complement Core Platform


Protalix BioTherapeutics Seeks Multiple Collaborative Partnerships To Complement Core Platform
JERUSALEM (dpa-AFX) - Protalix BioTherapeutics, Inc. (PLX), a biopharmaceutical company, said Wednesday that its President and Chief Executive Officer Dror Bashan has sent an annual letter to the company s shareholders and the investment community.
In the 2020 letter to shareholders, Bashan said that together with Chiesi Global Rare Diseases, the company s development and commercialization partner, it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration or FDA for PRX-102, for the treatment of adult patients with Fabry disease.
The company is looking forward to commercializing PRX-102 assuming the anticipated approval of the BLA in the second half of 2021. ....

Israel General , United States , Dror Bashan , Protalix Biotherapeutics Inc , Drug Administration , America Securities Inc , Chief Executive Officer Dror Bashan , Chiesi Global Rare Diseases , Biologics License Application , America Securities , Yael Hayon , Vice President , இஸ்ரேல் ஜநரல் , ஒன்றுபட்டது மாநிலங்களில் , திறோர் பாஷாண , அமெரிக்கா பத்திரங்கள் இன்க் , தலைமை நிர்வாகி அதிகாரி திறோர் பாஷாண , சிஐசி உலகளாவிய ரேர் நோய்கள் , உயிரியல் உரிமம் விண்ணப்பம் , அமெரிக்கா பத்திரங்கள் , துணை ப்ரெஸிடெஂட் ,